Carisma Therapeutics Implements Strategic Changes to Streamline Pipeline and Focus on Key Therapies Carisma Therapeutics announces strategic restructuring to prioritize in vivo therapies for fibrosis, oncology, and autoimmune diseases while reducing workforce.

Carisma Therapeutics Implements Strategic Changes to Streamline Pipeline and Focus on Key Therapies #United_States #Philadelphia #biotechnology #Carisma_Therapeutics #macrophage_therapy